News Conference News AHA 2025 Anticoagulation Alone Is Best in AF Patients a Year or More Out From PCI Todd Neale November 09, 2025
News Conference News AHA 2025 Stopping DOACs After Successful AF Ablation Feasible in Low-risk Patients: OCEAN Michael O'Riordan November 08, 2025
News Conference News AHA 2025 One Month of Dual Antithrombotic Therapy May Be Enough After PCI in AF Patients Todd Neale November 08, 2025
News Conference News ESC 2025 Treatment Based on ABC-AF Risk Scores Doesn’t Improve AF Outcomes Todd Neale September 08, 2025
News Conference News ESC 2025 AMALFI: Modest AF Detection With ECG Patch Screening Michael O'Riordan September 05, 2025
News Conference News ESC 2025 AQUATIC: More Than 6 Months After PCI, Don’t Use Aspirin With OAC Todd Neale September 01, 2025
News Conference News ESOC 2025 High Residual Risk of Recurrent Stroke Seen in AF Patients on Anticoagulants Todd Neale May 29, 2025
News Conference News AHA 2024 OPTION: LAAO Matches Up to DOACs After Ablation, but Questions Remain Todd Neale November 18, 2024
News Conference News AHA 2024 First-line Catheter Ablation Works for Post-MI VT Suppression: VANISH2 Caitlin E. Cox November 16, 2024
News Conference News TCT 2024 LAAO Outcomes Similar Regardless of Operator’s Specialty Todd Neale October 27, 2024
News Conference News ESC 2024 Streamlined European AF Guidelines Emphasize ‘Whole’ Patient Todd Neale September 06, 2024
News Conference News ESC 2024 STEEER-AF: Educating Healthcare Workers Improves Adherence to Guidelines Todd Neale September 06, 2024
News Conference News ESC 2024 Trial Challenges Continuation of Oral Anticoagulants During TAVI Todd Neale August 31, 2024
News Conference News NY Valves 2024 Leaks After LAAO Do Matter, Experts Agree Todd Neale June 10, 2024
News Conference News NY Valves 2024 Long-term Mortality After TAVI Lower With DOACs vs VKAs Todd Neale June 06, 2024
News Conference News ISC 2024 Speedier Anticoagulation Reversal Tied to Better ICH Outcomes Todd Neale February 15, 2024
News Conference News AHA 2023 NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear L.A. McKeown November 12, 2023
News Conference News AHA 2023 ARTESiA: Apixaban Lowers Stroke Risk in Subclinical AF Todd Neale November 12, 2023
News Conference News AHA 2023 Off-label DOAC Dosing Common in Hospitalized AF Patients, Too Todd Neale November 07, 2023
News Conference News EACTS 2023 Combined Surgical and Catheter Ablation Best for Persistent AF Michael O'Riordan October 12, 2023